Molecular interactions of rifabutin with membrane under acidic conditions

被引:4
作者
Pinheiro, Marina [1 ]
Silva, Ana Sofia [1 ]
Reis, Salette [1 ]
机构
[1] Univ Porto, REQUIMTE, Dept Ciencias Quim, Fac Farm, P-4050313 Oporto, Portugal
关键词
Membrane biophysical studies; Drug-membrane studies; Membrane models; Rifabutin; Tuberculosis; HELICOBACTER-PYLORI INFECTION; BIOPHYSICAL PROPERTIES; DPPC LIPOSOMES; PHARMACOKINETICS; TUBERCULOSIS; RIFAMPIN;
D O I
10.1016/j.ijpharm.2014.12.042
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This work focuses on the interaction of the anti-tuberculosis (anti-TB) drug, rifabutin (RFB) with cell membrane models formed by 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC). The experiments were performed under acidic conditions (i.e., pH 5.0) taking into account the pH conditions that RFB may find in the course of its in vivo pharmacological activity. The partition of the drug to the membrane was quantified through the partition coefficient (K-p). Fluorescence quenching studies were performed to predict the drug's location across the cell membrane model. The effect of RFB on the biophysical parameters of the cell membrane model was studied by steady-state anisotropy and small-angle X-ray scattering (SAXS). The overall results point to a marked interaction of RFB with cell membranes under acidic pH, which may be related with its pharmacological effects. The in vivo success of RFB may be associated with the drug's disordering effect of the membranes under acidic pH values environments, and consequently drug accumulation in the gastric infected tissues and inside phagolysosomes. On the other hand, the present study allowed establishing important correlations with the gastrointestinal side effects caused by RFB. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:63 / 69
页数:7
相关论文
共 32 条
[1]   Rifamycins - Obstacles and opportunities [J].
Aristoff, Paul A. ;
Garcia, George A. ;
Kirchhoff, Paul D. ;
Showalter, H. D. Hollis .
TUBERCULOSIS, 2010, 90 (02) :94-118
[2]   Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs [J].
Barry, CE ;
Slayden, RA ;
Sampson, AE ;
Lee, RE .
BIOCHEMICAL PHARMACOLOGY, 2000, 59 (03) :221-231
[3]   Molecular interactions in imatinib-DPPC liposomes [J].
Béni, S ;
Budai, M ;
Noszál, B ;
Gróf, P .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 27 (2-3) :205-211
[4]   Monitoring Biophysical Properties of Lipid Membranes by Environment-Sensitive Fluorescent Probes [J].
Demchenko, Alexander P. ;
Mely, Yves ;
Duportail, Guy ;
Klymchenko, Andrey S. .
BIOPHYSICAL JOURNAL, 2009, 96 (09) :3461-3470
[5]   Review article: rifabutin in the treatment of refractory Helicobacter pylori infection [J].
Gisbert, J. P. ;
Calvet, X. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (02) :209-221
[6]  
Gisbert Javier P, 2009, Therap Adv Gastroenterol, V2, P331, DOI 10.1177/1756283X09347109
[7]   Effect of fenitrothion on dipalmitoyl and 1-palmitoyl-2-oleoylphosphatidylcholine bilayers [J].
González-Baró, MR ;
Garda, H ;
Pollero, R .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2000, 1468 (1-2) :304-310
[8]   Interaction of 6-fluoroquinolones with dipalmitoylphosphatidylcholine monolayers and liposomes [J].
Grancelli, A ;
Morros, A ;
Cabañas, ME ;
Domènech, O ;
Merino, S ;
Vázquez, JL ;
Montero, MT ;
Viñas, M ;
Hernández-Borrell, J .
LANGMUIR, 2002, 18 (24) :9177-9182
[9]   NANOSECOND FLUORESCENCE ANISOTROPY DECAYS OF 1,6-DIPHENYL-1,3,5-HEXATRIENE IN MEMBRANES [J].
HILDENBRAND, K ;
NICOLAU, C .
BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 553 (03) :365-377
[10]   Probing DNA-cationic lipid interactions with the fluorophore trimethylammonium diphenyl-hexatriene (TMADPH) [J].
Hirsch-Lemer, D ;
Barenholz, Y .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1998, 1370 (01) :17-30